Central and Systemic Effects of a Vasopressin V1 Antagonist on MAP Recovery After Haemorrhage in Rats
Central and Systemic Effects of a Vasopressin V1 Antagonist on MAP Recovery After Haemorrhage in Rats
复制标题
加压素 V1 拮抗剂对大鼠出血后 MAP 恢复的中枢和全身影响
DOI:
--
复制
发表时间:
1988
影响因子:
3
通讯作者:
R. Hatton
中科院分区:
文献类型:
--
作者:
Janel V. Johnson;G. W. Bennett;R. Hatton
The present study examined the effects of central and peripheral administration of a vascular (V1) vasopressin (AVP) receptor antagonist on blood pressure, heart rate, and AVP levels in conscious rats. Rats subjected to rapid arterial haemorrhage were administered the AVP V1 antagonist [d(CH2)5Tyr(Me)AVP] either 5 min pre- or 20 min posthaemorrhage. Mean arterial blood pressure (MAP) was monitored for 45 min, after which the animais were killed and selected brain regions and plasma taken for AVP measurement. Intravenous (i.v.) administration of d(CH2)5Tyr(Me)AVP at 10 μg kg−1, but not 100 ng kg−1, significantly reduced MAP between 20 and 45 min posthaemorrhage compared with salinetreated controls. In contrast, administration of d(CH2)5Tyr(Me)AVP at 100 ng kg−1 intracerebroventricu-larly caused an attenuated MAP recovery to haemorrhage comparable with the effect of the antagonist at 10 μg kg−1 i.v. Haemorrhage caused a marked increase in circulating AVP levels, which was further enhanced in rats treated with the V1 antagonist at 10 μg kg−1 i.v., but no change in AVP levels of selected brain regions. The results indicate a role for AVP in MAP recovery following haemorrhage which may be centrally mediated.